The effect of metformin on treatment of squamous cell carcinoma of neck

Phase 2

• Conditions: Malignant neoplasm of larynx.; Malignant neoplasm of larynx, unspecified; C32.9

• Registration Number: IRCT20191203045594N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 December 2019

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

All patients with biopsy-proven squamous cell carcinoma of hypopharynx, nasopharynx, and larynx

Exclusion Criteria

All patients with distant metastasis
Hypersensitivity to metformin

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The complete response. Timepoint: 12 weeks after the intervention. Method of measurement: Spiral CT scan.;Toxicity. Timepoint: Weekly. Method of measurement: Common Terminology Criteria for Adverse Events (CTCAE).